top of page
Blog Tool
Search


Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPSâ„¢)
The NIH has activated Phase II funding of Sensydia’s Fast-Track STTR grant to support real-world clinical utility studies of the Cardiac Performance System (CPS™). This non-dilutive funding marks a key milestone as the company continues to validate CPS for patients with heart failure and pulmonary hypertension.
Admin
Jun 92 min read
Â
Â
Â


Sensydia Appoints Rusty Page as President and Chief Operating Officer to Support Growth and Commercialization of the Cardiac Performance System (CPSâ„¢)
Industry veteran brings over 20 years of medical device leadership to guide operations, quality, and infrastructure as Sensydia advances toward FDA submission and commercialization of the Cardiac Performance System (CPSâ„¢).
Admin
May 62 min read
Â
Â
Â


Sensydia Announces First Patient Enrolled in Pivotal Study of Non-Invasive Cardiac Performance System (CPSâ„¢)
Sensydia has enrolled the first patient in its pivotal clinical study evaluating the Cardiac Performance System (CPS™), a non-invasive solution for hemodynamic assessment. This milestone advances CPS™ toward FDA submission and supports Sensydia’s mission to transform the management of heart failure and other cardiac conditions through faster, safer diagnostics.
Admin
Apr 282 min read
Â
Â
Â


Clinical data presented at ACC 2025 shows Sensydia CPSâ„¢ provides accurate assessment of mean pulmonary artery pressure non-invasively
Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate...
Admin
Mar 293 min read
Â
Â
Â


Sensydia Completes Fifth Study for Heart-Sound AI
Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate...
Admin
Jan 16, 20243 min read
Â
Â
Â


Sensydia secures $3M NIH grant to advance AI-based cardiac assessment platform
NIH STTR Fast-Track grant helps propel Sensydia's non-invasive CPS platform building on recent funding round Los Angeles, CA – June 5,...
Admin
Jun 5, 20232 min read
Â
Â
Â


Sensydia raises $8M round to advance breakthrough CPS cardiac assessment platform
Sensydia continues to push the boundaries of AI in heart function assessment Los Angeles, CA – May 9, 2023 – Non-invasive cardiac...
Admin
May 9, 20233 min read
Â
Â
Â


Sensydia Achieves Study Target for Heart-Sound AI
Completion of enrollment for this 225-subject study is a key milestone on the path to delivering the first device for non-invasive and...
Admin
Feb 6, 20233 min read
Â
Â
Â


Sensydia Receives FDA Breakthrough Device Designation for CPS Non-Invasive Cardiac Monitoring Device
External device uses heart sound and AI to deliver rapid cardiac function assessments via tablet to expand hemodynamic evaluation beyond...
Admin
Jan 19, 20222 min read
Â
Â
Â


Sensydia Appoints Anthony Arnold as President and Chief Executive Officer
Los Angeles – October 1, 2019 – Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function,...
Admin
Oct 1, 20192 min read
Â
Â
Â


FDA Clears Sensydia’s Cardiac Performance System
The Sensydia Cardiac Performance System (CPS) is the first patient-worn system to provide Ejection Fraction information to clinicians for...
Admin
Jun 18, 20182 min read
Â
Â
Â


Sensydia Completes Series B Financing
Sensydia Corporation announces that it has complete a Series B financing. The financing was led by Colle Capital and included all Series...
Admin
Jul 1, 20171 min read
Â
Â
Â


Sensydia Completes Series A Financing
Sensydia Corporation has completed its first round of financing which will be used to develop its patent pending technology to detect...
Admin
Apr 4, 20161 min read
Â
Â
Â
bottom of page